Lung Disease News – Cites a new study conducted by researchers at the Geisel School of Medicine, in collaboration with Novartis Pharmaceutical, which found that mannitol co-treatment with the antibiotic tobramycin did not enhance the antibiotic’s bacterial killing effect in a cystic fibrosis model.
Articles by: Geisel Communications
In Reversal, Death Rates Rise For Middle-Aged Whites
NPR – Continued coverage of comments by Jonathan Skinner, a professor of economics and of medicine at the Geisel School of Medicine, who co-authored a commentary accompanying recent research about how suicides and drug overdoses have contributed to a marked increase in the mortality rate for middle-aged white Americans.
Death Rates Rising for Middle-Aged White Americans, Study Finds
The New York Times – Article quotes Ellen Meara and Jonathan Skinner, both associate professors of the Dartmouth Institute for Health Policy and Clinical Practice and adjunct associate professors of economics, who co-authored a commentary accompanying recent research about how suicides and drug overdoses have contributed to a marked increase in death rates for middle-aged white Americans. “It is difficult to find modern settings with survival losses of this magnitude,” wrote Meara and Skinner. (Picked up by Herald Recorder.
More Research Suggests Fast-Food Advertising Works on Children
The New York Times – Quotes Jennifer Emond, instructor in epidemiology and co-author of a recent study which found that children who watch TV shows with ads for kids’ fast food meals that include toys are more likely to influence the entire family to eat more frequently at fast food restaurants.
Kids Meals, Toys and TV Ads Add Up to Frequent Fast Food: Study
U.S. News & World Report via Health Day News – Continued coverage of research conducted by Jennifer Emond, instructor in epidemiology and co-author of a recent study which found that children who watch TV shows with ads for kids’ fast food meals that include toys are more likely to influence the entire family to eat more frequently at fast food restaurants.
Miracle or Hype? News Reports Often Inflate Cancer Drugs’ Success
USA Today – Cites comments by Lisa Schwartz, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, about a study of the media’s use of over-the-top terms when reporting on new cancer drugs.
Making Sense of New Mammogram Guidelines
NHPR – As a guest on NHPR’s “The Exchange,” H. Gilbert Welch, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, discusses the American Cancer Society’s new recommendation to raise the age for breast cancer screenings from 40 to 45, saying that too many false positives have led to unnecessary and even harmful treatment.
Is the Latest Prescription Sleep Drug Effective?
KOTA News – Cites a study conducted by researchers at the Geisel School of Medicine in collaboration with Consumer Reports, where they analyzed the sleep medicine Belsomra’s effectiveness and safety. The research found that people taking 15 or 20 milligrams of Belsomra got an average of about 16 minutes more sleep per night and fell asleep about 6 minutes faster compared with those who took a placebo.
Dartmouth Breast Cancer Researcher Receives $450,000 Grant
Valley News – Todd Miller, assistant professor of pharmacology and toxicology and scientific director of the Comprehensive Breast Program at Dartmouth’s Norris Cotton Cancer Center, has received a $450,000 grant from Susan G. Komen to study therapy resistance in breast cancer. “Understanding the biology behind tumor response to estrogens will legitimize this therapy, enable identification of patients with tumors most likely to respond, and provide strategies to enhance the therapeutic effects of estrogens,” says Miller.
DHMC Surgeon Chosen for Clinician-Entrepreneur Fellowship
Valley News – Richard J. Barth Jr., professor of surgery and chief of the section of general surgery at Dartmouth-Hitchcock Medical Center, is the first recipient of the Dartmouth SYNERGY Clinical and Translational Science Institute’s synergy clinician-entrepreneur fellowship. The one-year fellowship will provide Barth with resources and dedicated time to develop and study the commercial potential of a new system to improve certain types of breast cancer surgery.